Blueprint Medicines Market Cap

Blueprint Medicines has a market cap or net worth of €7.21 billion as of July 16, 2025. Its market cap has increased by 13.61% in one year.

Market Cap

7.21B

Enterprise Value

7.05B

Revenue

520.07M

Ranking

n/a

PE Ratio

n/a

Stock Price

€105.10

Market Cap Chart

Since April 30, 2015, Blueprint Medicines's market cap has increased from 435.41M to 7.21B, an increase of 1,556.14%. That is a compound annual growth rate of 31.62%.

Market Cap History

Date	Market Cap	% Change
Jul 15, 2025	7.21B	34.74%
Dec 31, 2024	5.35B	5.50%
Dec 29, 2023	5.07B	106.83%
Dec 30, 2022	2.45B	-55.74%
Dec 31, 2021	5.54B	8.45%
Dec 31, 2020	5.11B	45.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
UniCredit	90.72B
Intesa Sanpaolo	87.65B
Enel SpA	80.82B
Ferrari	74.68B
Assicurazioni Generali	47.40B
Eni S.p.A.	43.28B
Leonardo S.p.a.	28.01B
Stellantis	24.29B

Market Cap Rankings